|This Slide: #83 of 100|
Slide #83. BioScrip, Inc. — HomeChoice Partners, Inc.
BioScrip, Inc. (BIOS)
HomeChoice Partners, Inc.
BioScrip, Inc. (NASDAQ: BIOS) today announced the February 1, 2013 closing of its previously announced agreement to acquire HomeChoice Partners, Inc. ("HomeChoice"), a leading provider of alternate-site infusion pharmacy services, for $70.0 million in cash. HomeChoice was a majority-owned subsidiary of DaVita HealthCare Partners Inc. (NYSE: DVA). The purchase price is subject to adjustment pursuant to the terms of the agreement including potential additional consideration based on the results of operations. BioScrip also expects to realize the value of a future tax benefit estimated at $3.9 million as a result of the transaction.
Option Care Health is a provider of infusion and home care management solutions. Co. partners with physicians, hospital systems, payors, pharmaceutical manufacturers and nursing facilities to provide patients access to post-acute care services. Whether in the home, physician office, ambulatory infusion center, nursing facility or other alternate sites of care, Co. provides products, services and condition-specific clinical management programs tailored to improve the care of individuals with health conditions such as gastrointestinal abnormalities, infectious diseases, cancer, multiple sclerosis, organ and blood cell transplants, bleeding disorders, immune deficiencies and heart failure.
Open the BIOS Page at The Online Investor »
Strong Buy (4.00 out of 4)
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite